Modexa Dosage/Direction for Use

Dosage: After initial priming of the MODEXA nasal spray suspension (10 actuations, until a uniform spray is observed), each actuation delivers approximately 100 mg of mometasone furoate nasal spray suspension, containing mometasone furoate monohydrate equivalent to 50 mcg mometasone furoate. If the spray pump has not been used for 14 days or longer, it should be reprimed with 2 actuations, until a uniform spray is observed, before next use.
Shake container well before each use.
Seasonal allergic or perennial rhinitis: Adults (including geriatric patients) and adolescents: The usual recommended dose for prophylaxis and treatment is two sprays (50 mcg/spray) in each nostril once daily (total dose 200 mcg). Once symptoms are controlled, dose reduction to one spray in each nostril (total dose 100 mcg) may be effective for maintenance. If symptoms are inadequately controlled, the dose may be increased to a maximum daily dose of four sprays in each nostril once daily (total dose 400 mcg). Dose reduction is recommended following control of symptoms.
Clinically significant onset of action occurs as early as 12 hours after the first dose.
Children between the ages of 2 and 11 years: The usual recommended dose is one spray (50 mcg/spray) in each nostril once daily (total dose 100 mcg). Administration to young children should be aided by an adult.
Nasal Polyposis: Adults (including geriatric patients) and adolescents 18 years of age and older: The usual recommended dose for polyposis is two sprays (50 mcg/spray) in each nostril twice daily (total daily dose of 400 mcg). Once symptoms are adequately controlled, dose reduction to two sprays in each nostril once daily (total daily dose 200 mcg) is recommended.
Acute Rhinosinusitis: The usual recommended dose for acute rhinosinusitis is two sprays (50 mcg/spray) in each nostril twice daily (total daily dose of 400 mcg). If symptoms worsen during treatment, the patient should be advised to consult their physician.
Adjunctive treatment of acute episodes of sinusitis: Adults (including geriatric patients) and adolescents 12 years of age and older: The usual recommended dose is two sprays (50 mcg/spray) in each nostril twice daily (total dose 400 mcg). If symptoms are inadequately controlled, the dose may be increased to four sprays (50 mcg/spray) in each nostril twice daily (total dose 800 mcg).